Research recommendations for selected IARC-classified agents

Elizabeth M Ward1, Paul A Schulte, Kurt Straif

  • 1Epidemiology and Surveillance Research, American Cancer Society, Atlanta Georgia 30303, USA. elizabeth.ward@cancer.org

Abstract

Insights

Identifying research gaps for 20 occupational carcinogens is crucial. New studies are needed to clarify human cancer risks from these agents, considering multiple toxicity pathways and mechanisms.

Area of Science:

  • Occupational Health
  • Toxicology
  • Carcinogenesis

Background:

  • Substantial evidence suggests some occupational agents are carcinogenic, but human data remain inconclusive.
  • Prioritization of 20 agents was based on widespread human exposure and potential carcinogenicity.

Purpose of the Study:

  • To identify critical research gaps and needs for 20 prioritized occupational agents.
  • To guide future research for resolving uncertainties in carcinogen classification.

Main Methods:

  • Systematic review of new data published since the last International Agency for Research on Cancer (IARC) Monograph.
  • Expert meetings to discuss agents, data gaps, and research approaches.

Main Results:

  • Overarching issues include understanding multiple toxicity pathways and mechanisms (epigenetic, oxidative stress, immune, hormonal).
  • Specific data gaps and research needs were identified for individual agents.

Conclusions:

  • Occupational studies are vital for understanding cancer mechanisms and informing prevention.
  • Epidemiologic studies are critical for future carcinogen classification and risk assessment amidst evolving scientific challenges.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Criteria for Causality: Bradford Hill Criteria - II01:28

Criteria for Causality: Bradford Hill Criteria - II

The Bradford Hill criteria serve as guidelines for establishing causative links in epidemiological research. Beyond Strength, Consistency, Specificity, and Temporality, key criteria also include Biological Gradient, Plausibility, Coherence, Experiment, and Analogy. These principles assist scientists in assessing the likelihood of causation in complex biological contexts. Below is a summary of these concepts:
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers01:17

Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers

Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...